Invokana Settlements - What You Should Know

Invokana was marketed as a Janssen’s product and with its easy dietary restrictions compared to the other similar drugs, this became one of the most well-liked medications for diabetes. Unfortunately, soon after it was released for public use, there were plenty of adverse reports submitted to the FDA and the victims claimed for invokana settlements. In fact, in May 2015, the administration body warned about Invokana's potentially life-altering health effect diabetic ketoacidosis (which is the condition of having excess amount of ketones in the body) and how it is an needless risk associated with the drug.
In September 2015, there was a revised FDA warning which highlighted about how the drug can increase the risk of bone fracture and have reduced bone mineral density. The patients taking Invokana are twice more likely to face the risk of leg or foot amputation than those thriving on other similar medication.
The other complications associated with the drug are:
  • bone fracture
  • acute kidney complications
  • impairment of renal function
  • increased low-density lipoprotein
  • hyperkalemia
 What are the main points of disagreement in invokana settlement?
The following are the main points of concern in the lawsuit which the attorneys fight for:
  • failed to inform the patients and physicians about the risks of taking invokana
  • no proper clinical safety trials was conducted
  • not informing the proper risks to the FDA about the drug
  • continued misrepresenting the drug even when there were reports about the side effects
To find out whether you are eligible for the damage awards or if you have been unnecessarily affected from the complications of Invokana, get in touch with the expert attorneys. To understand the process of applying for the lawsuit and to get a free consultation from the experts, get in touch with the team of Invokanasideeffects.us. Know the latest update and find your lawsuit through an appointment over (855) 973-4136.

Comments

Post a Comment

Popular posts from this blog

Three main side effects of Invokana you should know

Image
Invokana is part of a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors which has seen a huge response in the treatment of adults with type 2 diabetes. Type 2 diabetes is a disease in which a person has high levels of sugar in his or her blood, when the pancreas fails to create enough of insulin and regulate blood sugar. Invokana is manufactured by Janssen Pharmaceuticals, Inc., (a division of Johnson & Johnson) is supposed to help patients achieve glycemic control.  Unfortunately, there have been reports which suggest otherwise. The patients with diabetic complications led patients developing kidney injury and kidney failure, diabetic ketoacidosis, and toe, foot, or leg amputations after taking the drug. The following are the main   side effects of invokana : The kidneys are a vital component in the workings of Invokana, but the drug can develop reduced kidney function or kidney failure. When this occurs, the kidneys are unable to filter ou
Read more

All About Cases And Settlements Involving Invokana

Image
Invokana is an SGLT2 inhibitor designed to block a specific protein that helps the body reabsorb glucose in the bloodstream.  Sadly, many patients who are prescribed Invokana to treat their Type-II diabetes have experienced serious complications, often resulting fatal. Many lawsuits have been filed against the manufacturer. Invokana lawsuit update claims that the drug manufacturer didn’t warn the patients and physicians about the possible side effects.  The legal papers plainly insist that if the drug manufacturer had prior and adequate warnings against Invokana and its side effects, the physicians would have informed the patients of the risks, if prescribed at all.  Some of the most prominent cases involving Invokana are: September 2015: An Invokana lawsuit for $1 billion (general and special damages more than $500 million each) was filed on behalf of Canadians in Ontario. Under a request for class-action status, the manufacturers involve a woman who too
Read more